Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapeutics for oncology and rare diseases, today announced ...

Also known as Ziihera, the antibody treatment targets a protein called HER2, which stimulates tumour growth. It works by ...

The sister of a serving West Midlands Police officer has demanded that images of her body be shown during the inquest into ...

A former patient of jailed surgeon Ian Paterson made complaints about him after he left mounds of flesh behind following two ...

Phase 3 KEYNOTE-B15 data demonstrate that perioperative enfortumab vedotin and pembrolizumab significantly improve EFS, OS, and pCR compared with standard chemotherapy.

EV-304 trial. The U.S. Food and Drug Administration (FDA) has granted Priority Review to a supplemental biologics license application for enfortumab vedotin-ejfv (Padcev) in combination with ...

FDA grants Priority Review for Padcev plus Keytruda in muscle-invasive bladder cancer, showing improved survival and reduced ...

A deep learning platform may help predict how people with advanced lung cancer will respond to immunotherapy, according to study results.Patients determined by a biology-guided AI model to be at high ...

Researchers analyze experiences and characteristics of a cohort of adolescent and young adult patients with cancer who ...

New research challenges assumption that small organ located behind sternum becomes unimportant after childhood ...

A new update from the American Gastroenterological Association (AGA) urges stronger prevention efforts and better ...

Vita Sara Blechner’s life changed on a Saturday afternoon. The middle school librarian was home in Oceanside, New York, when ...